Consorzio per Valutazioni Biologiche e Farmacologiche Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2012
NCT01740713
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Consorzio per Valutazioni Biologiche e Farmacologiche